Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?

Avalo Therapeutics Ownership Summary

Avalo Therapeutics is owned by 61.50% institutional investors, and 38.50% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.55% of its assets in Avalo Therapeutics shares.

AVTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Avalo Therapeutics	61.50%	-	38.50%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2022	42	-34.38%	69,378,775	-10.69%	61	1.30%	14	-30.00%	19	-32.14%
Mar 31, 2022	64	-12.33%	77,679,178	-2.87%	68	1.09%	20	-52.38%	28	86.67%
Dec 31, 2021	73	-3.95%	79,978,021	-0.58%	79	1.24%	42	-42.47%	15	-
Sep 30, 2021	76	-	80,445,353	-	80	-	73	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	165.80K	1.55%	-
Fidelity Extended Market Index	51.27K	0.48%	-327.00
Fidelity Total Market Index	21.45K	0.20%	-17.00
Extended Equity Market Fund K	19.53K	0.18%	60.00
Fidelity Series Total Market Index	13.40K	0.13%	-
NT Ext Equity Mkt Idx Fd - NL	11.56K	0.11%	-
Northern Trust Extended Eq Market Idx	10.61K	0.10%	8.20K
NT Ext Equity Mkt Idx Fd - L	10.61K	0.10%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	9.00K	0.08%	-164.00
Spartan Extended Market Index Pool E	6.37K	0.06%	327.00

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	2	-
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-

AVTX Ownership FAQ

Who Owns Avalo Therapeutics?

Avalo Therapeutics shareholders are primarily institutional investors at 61.50%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Avalo Therapeutics's industry, Biotech Stocks , is 68.48%, which Avalo Therapeutics falls below.

Does Blackrock own Avalo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avalo Therapeutics.

Who is the top mutual fund holder of Avalo Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Avalo Therapeutics shares, with 1.55% of its total shares outstanding invested in 165.8K Avalo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools